Market Analysis and Insights: Global Vaccine Contract Manufacturing Market
The global Vaccine Contract Manufacturing market size is projected to reach US$ 2558.5 million by 2028, from US$ 1731.5 million in 2021, at a CAGR of 5.3% during 2022-2028.
Fully considering the economic change by this health crisis, Fill-Finish accounting for % of the Vaccine Contract Manufacturing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical Companies segment is altered to an % CAGR throughout this forecast period.
China Vaccine Contract Manufacturing market size is valued at US$ million in 2021, while the North America and Europe Vaccine Contract Manufacturing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vaccine Contract Manufacturing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vaccine Contract Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vaccine Contract Manufacturing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vaccine Contract Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vaccine Contract Manufacturing market.
Global Vaccine Contract Manufacturing Scope and Market Size
Vaccine Contract Manufacturing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Vaccine Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application
- Pharmaceutical Companies
- Biotech Companies
- Others
By Company
- Diosynth
- Emergent BioSolutions
- Goodwin Biotechnology
- Bavarian Nordic
- Soligenix Inc
- Catalent Biologics
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Fill-Finish
- 1.2.3 Bulk Product
- 1.3 Market by Application
- 1.3.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Biotech Companies
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Vaccine Contract Manufacturing Market Perspective (2017-2028)
- 2.2 Vaccine Contract Manufacturing Growth Trends by Region
- 2.2.1 Vaccine Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Vaccine Contract Manufacturing Historic Market Size by Region (2017-2022)
- 2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Region (2023-2028)
- 2.3 Vaccine Contract Manufacturing Market Dynamics
- 2.3.1 Vaccine Contract Manufacturing Industry Trends
- 2.3.2 Vaccine Contract Manufacturing Market Drivers
- 2.3.3 Vaccine Contract Manufacturing Market Challenges
- 2.3.4 Vaccine Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Vaccine Contract Manufacturing Players by Revenue
- 3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2017-2022)
- 3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2017-2022)
- 3.2 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
- 3.4 Global Vaccine Contract Manufacturing Market Concentration Ratio
- 3.4.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2021
- 3.5 Vaccine Contract Manufacturing Key Players Head office and Area Served
- 3.6 Key Players Vaccine Contract Manufacturing Product Solution and Service
- 3.7 Date of Enter into Vaccine Contract Manufacturing Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Contract Manufacturing Breakdown Data by Type
- 4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2017-2022)
- 4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2023-2028)
5 Vaccine Contract Manufacturing Breakdown Data by Application
- 5.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2017-2022)
- 5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Vaccine Contract Manufacturing Market Size (2017-2028)
- 6.2 North America Vaccine Contract Manufacturing Market Size by Type
- 6.2.1 North America Vaccine Contract Manufacturing Market Size by Type (2017-2022)
- 6.2.2 North America Vaccine Contract Manufacturing Market Size by Type (2023-2028)
- 6.2.3 North America Vaccine Contract Manufacturing Market Share by Type (2017-2028)
- 6.3 North America Vaccine Contract Manufacturing Market Size by Application
- 6.3.1 North America Vaccine Contract Manufacturing Market Size by Application (2017-2022)
- 6.3.2 North America Vaccine Contract Manufacturing Market Size by Application (2023-2028)
- 6.3.3 North America Vaccine Contract Manufacturing Market Share by Application (2017-2028)
- 6.4 North America Vaccine Contract Manufacturing Market Size by Country
- 6.4.1 North America Vaccine Contract Manufacturing Market Size by Country (2017-2022)
- 6.4.2 North America Vaccine Contract Manufacturing Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Vaccine Contract Manufacturing Market Size (2017-2028)
- 7.2 Europe Vaccine Contract Manufacturing Market Size by Type
- 7.2.1 Europe Vaccine Contract Manufacturing Market Size by Type (2017-2022)
- 7.2.2 Europe Vaccine Contract Manufacturing Market Size by Type (2023-2028)
- 7.2.3 Europe Vaccine Contract Manufacturing Market Share by Type (2017-2028)
- 7.3 Europe Vaccine Contract Manufacturing Market Size by Application
- 7.3.1 Europe Vaccine Contract Manufacturing Market Size by Application (2017-2022)
- 7.3.2 Europe Vaccine Contract Manufacturing Market Size by Application (2023-2028)
- 7.3.3 Europe Vaccine Contract Manufacturing Market Share by Application (2017-2028)
- 7.4 Europe Vaccine Contract Manufacturing Market Size by Country
- 7.4.1 Europe Vaccine Contract Manufacturing Market Size by Country (2017-2022)
- 7.4.2 Europe Vaccine Contract Manufacturing Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size (2017-2028)
- 8.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type
- 8.2.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Vaccine Contract Manufacturing Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application
- 8.3.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Vaccine Contract Manufacturing Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region
- 8.4.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Vaccine Contract Manufacturing Market Size (2017-2028)
- 9.2 Latin America Vaccine Contract Manufacturing Market Size by Type
- 9.2.1 Latin America Vaccine Contract Manufacturing Market Size by Type (2017-2022)
- 9.2.2 Latin America Vaccine Contract Manufacturing Market Size by Type (2023-2028)
- 9.2.3 Latin America Vaccine Contract Manufacturing Market Share by Type (2017-2028)
- 9.3 Latin America Vaccine Contract Manufacturing Market Size by Application
- 9.3.1 Latin America Vaccine Contract Manufacturing Market Size by Application (2017-2022)
- 9.3.2 Latin America Vaccine Contract Manufacturing Market Size by Application (2023-2028)
- 9.3.3 Latin America Vaccine Contract Manufacturing Market Share by Application (2017-2028)
- 9.4 Latin America Vaccine Contract Manufacturing Market Size by Country
- 9.4.1 Latin America Vaccine Contract Manufacturing Market Size by Country (2017-2022)
- 9.4.2 Latin America Vaccine Contract Manufacturing Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size (2017-2028)
- 10.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type
- 10.2.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Vaccine Contract Manufacturing Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application
- 10.3.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Vaccine Contract Manufacturing Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country
- 10.4.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Diosynth
- 11.1.1 Diosynth Company Details
- 11.1.2 Diosynth Business Overview
- 11.1.3 Diosynth Vaccine Contract Manufacturing Introduction
- 11.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2017-2022)
- 11.1.5 Diosynth Recent Developments
- 11.2 Emergent BioSolutions
- 11.2.1 Emergent BioSolutions Company Details
- 11.2.2 Emergent BioSolutions Business Overview
- 11.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
- 11.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2017-2022)
- 11.2.5 Emergent BioSolutions Recent Developments
- 11.3 Goodwin Biotechnology
- 11.3.1 Goodwin Biotechnology Company Details
- 11.3.2 Goodwin Biotechnology Business Overview
- 11.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
- 11.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2017-2022)
- 11.3.5 Goodwin Biotechnology Recent Developments
- 11.4 Bavarian Nordic
- 11.4.1 Bavarian Nordic Company Details
- 11.4.2 Bavarian Nordic Business Overview
- 11.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
- 11.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2017-2022)
- 11.4.5 Bavarian Nordic Recent Developments
- 11.5 Soligenix Inc
- 11.5.1 Soligenix Inc Company Details
- 11.5.2 Soligenix Inc Business Overview
- 11.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
- 11.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2017-2022)
- 11.5.5 Soligenix Inc Recent Developments
- 11.6 Catalent Biologics
- 11.6.1 Catalent Biologics Company Details
- 11.6.2 Catalent Biologics Business Overview
- 11.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
- 11.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2017-2022)
- 11.6.5 Catalent Biologics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer